Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 9
Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
See original article:
Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy - May 01, 2022
PDF
Correction
Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
Online download statistics by month:
Online download statistics by month: September 2022 to May 2023
Abstract
Full
Pdf
Sep 2022
0
139
10
Oct 2022
0
105
28
Nov 2022
0
59
14
Dec 2022
0
54
13
Jan 2023
0
37
8
Feb 2023
0
38
9
Mar 2023
0
13
1
Apr 2023
0
17
6
May 2023
0
15
3
Total
0
477
92
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF